May 9, 2013
Baxter Ltd. announced on May 7 that its cell culture-based influenza vaccine (prototype) manufactured in the Czech Republic and codeveloped in Japan with Takeda Pharmaceutical has received approval. The vaccine received an orphan drug designation in September last year based...read more